BRCA1 and ovarian carcinoma: Moreover, in regard to rs3817198, all of the women with mutations in BRCA1 and with ovarian cancer had at least one T allele (with 88.9 % being TT homozygotes); however, the same pattern was not observed for the women with mutations in BRCA2 and a personal history of ovarian cancer (p = 0.006).